# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE004-SYN-TD
- Date: 1527-10-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Brandt-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Thirteen-week review: attacks, hearing, mood and stone prevention. **S**

## History of present illness

Professor Luther returns five weeks after his six-week review. He has had no vertigo attack for eight weeks and has preached and lectured without one. The tinnitus is still there but quieter. He has done the printed balance exercises daily; the first appointment with the vestibular physical therapist is next week, because of a waiting list. He collected the 24-hour urine on an ordinary working day. He keeps the salt limit at home but not at dinners with guests, and he admits he drinks little water. His mood is clearly better: he sleeps seven hours, enjoys his work and his household again, and has had eight therapy sessions. He has no thoughts of harming himself. **S**

| Element | Detail |
|---|---|
| Attacks | None for eight weeks |
| Balance therapy | Home exercises; first therapist visit next week |
| Urine | 24-hour collection done |
| Mood | Better; PHQ-9 6 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Ears, nose, mouth, and throat | Positive | Quieter left-ear tinnitus; no fullness |
| Neurological | Negative | No vertigo; unsteadiness much less |
| Genitourinary | Negative | No flank pain |
| Psychiatric | Negative | Mood good; no suicidal ideation |

4 systems reviewed. **S**

## Current medications

- Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a time **S**
- Hydrochlorothiazide 25 mg tablet, one by mouth each morning **S**
- Sertraline 50 mg tablet, one by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 84.4 kg; BMI 27.6 kg/m². All vital signs are synthetic.

Sodium: 137 mmol/L; Potassium: 3.8 mmol/L; Creatinine: 0.98 mg/dL; Calcium: 9.9 mg/dL; eGFR: 98 mL/min/1.73 m²; 24-hour urine volume: 1.6 L/(24.h) (low); 24-hour urine calcium: 190 mg/(24.h); 24-hour urine oxalate: 38 mg/(24.h); 24-hour urine citrate: 410 mg/(24.h) (low); 24-hour urine sodium: 140 mmol/(24.h) (high); 24-hour urine uric acid: 680 mg/(24.h); 24-hour urine creatinine: 1750 mg/(24.h); PHQ-9: 6. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 137 mmol/L at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 3.8 mmol/L at this visit **S**
- Creatinine: 1.02 mg/dL at baseline, 0.98 mg/dL at this visit **S**
- Calcium: 9.7 mg/dL at baseline, 9.9 mg/dL at this visit **S**
- eGFR: 94 mL/min/1.73 m² at baseline, 98 mL/min/1.73 m² at this visit **S**
- PHQ-9: 15 at baseline, 6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Blood pressure 120/78, pulse 70; weight 84.4 kg, BMI 27.6 |
| Neurological | No nystagmus; tandem gait steady; Romberg steady on foam with eyes closed |
| Psychiatric | Euthymic, reactive affect; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ménière disease of the left ear, controlled** (H81.02). No attacks for eight weeks. Repeat audiogram: the left low-frequency loss has improved to 30 to 35 dB, with word recognition 92 percent. Sodium 137 and potassium 3.8 mmol/L on the thiazide. Intratympanic steroid is not needed. **S**
   - Continue hydrochlorothiazide and the salt limit.
   - Vestibular therapy as booked.
   - Audiogram with any change in hearing, and yearly.
   - Tinnitus counseling offered; hearing aid not needed now.
2. **Recurrent calcium oxalate stones** (Z87.442). 24-hour urine: volume 1.6 liters (low), sodium 140 mmol (high, about 3,200 mg of sodium), citrate 410 mg (low), calcium 190 mg, oxalate 38 mg and uric acid 680 mg (normal); creatinine 1,750 mg shows a complete collection. The calcium is normal on the thiazide. Low volume, high sodium and low citrate are the targets. **S**
   - Drink enough to pass at least 2.5 liters of urine a day: a full glass with each meal and at each lecture break.
   - Dietitian referral for sodium below 2,300 mg a day, which also helps the Ménière disease.
   - Normal dietary calcium; lemon or orange in water for citrate; potassium citrate if citrate stays low.
   - Continue hydrochlorothiazide.
   - Repeat 24-hour urine in about six months.
3. **Recurrent depression, responding** (F33.1). PHQ-9 6, a 60 percent fall from 15: response, not yet remission. **S**
   - Continue sertraline 50 mg for at least six to twelve months after remission, given a recurrent course.
   - Continue therapy every two weeks.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Vertigo attack diary: number, duration, hearing, tinnitus, fullness, headache | Every visit | Completed today | No attacks for eight weeks; no headaches; Dizziness Handicap Inventory 18 (Dizziness Handicap Inventory in the notes; no LOINC code used) |
| Examination | Audiometry (pure-tone and speech) | At diagnosis; repeat at about three months and with any change in hearing | Completed today | Left low-frequency loss 30 to 35 dB; word recognition 92 percent left; right normal |
| Laboratory | Sodium, potassium, creatinine and calcium on a thiazide with an SSRI | Two to four weeks after starting, then every three to six months | Completed today | Sodium 137, potassium 3.8 mmol/L, creatinine 0.98 mg/dL, calcium 9.9 mg/dL |
| Referral | Vestibular rehabilitation for chronic imbalance | When imbalance persists between attacks | Deferred | Protocol deviation: referred at the six-week visit, but the first therapist appointment is next week because of a waiting list. He has done the printed home exercises daily, his balance has improved, and he has not fallen, so no harm resulted. Corrective action: the clinic now gives the home program at the time of referral and asks for a telephone slot when the wait is over three weeks |
| Medication safety | Intratympanic steroid for persistent disabling attacks | If attacks persist after about three months of noninvasive treatment | Not indicated | No attacks for eight weeks |
| Self-management | Sodium, caffeine and alcohol limits | Every visit | Completed today | 24-hour urine sodium 140 mmol, still high; dietitian referral |
| Laboratory | 24-hour urine for a recurrent stone former | About six weeks after the stone passed; then within six months of starting treatment | Completed today | Volume 1.6 L/day, calcium 190, oxalate 38, citrate 410 (low), uric acid 680 and creatinine 1,750 mg/day, sodium 140 mmol/day (high) |
| Laboratory | Repeat 24-hour urine on treatment | Within six months of starting prevention | Due | In about six months |
| Imaging | Kidney imaging for new stones | Yearly, or with symptoms | Up to date | Ultrasound five weeks ago clear |
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 6, a 60 percent fall from 15 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation since the last visit; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed doses; no side effects |
| Self-management | Psychotherapy attendance | Weekly, then every two weeks | Completed today | Eight CBT sessions attended |

## Goal progress

- Fewer and milder vertigo attacks: no more than one disabling attack a month by three months, and able to preach without fear of an attack. Outcome by 1527-10-27: One attack between the second and six-week visits and none in the five weeks before the thirteen-week visit; preaching again. **S**
- Depression response (PHQ-9 down by at least 50 percent) by three months. Outcome by 1527-10-27: PHQ-9 6 at thirteen weeks, down 60 percent from 15. **S**
- Sodium intake below 2,300 mg a day. In progress; target 1528-01-31. **S**
- Urine volume of at least 2.5 liters a day. In progress; target 1528-01-31. **S**

## Guideline basis

- Clinical Practice Guideline: Ménière's Disease (2020), American Academy of Otolaryngology-Head and Neck Surgery Foundation (Basura GJ, et al. Otolaryngol Head Neck Surg 2020;162(2 Suppl):S1-S55)
- Medical Management of Kidney Stones: AUA Guideline (2014), American Urological Association (Pearle MS, et al. J Urol 2014;192(2):316-324)
- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Dietitian in two weeks. Vestibular therapy next week. Review in three months; 24-hour urine in six months. **S**

